<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01690338</url>
  </required_header>
  <id_info>
    <org_study_id>CSA-NMB-001</org_study_id>
    <nct_id>NCT01690338</nct_id>
  </id_info>
  <brief_title>A Study of Residual Curarization Incidence in China</brief_title>
  <official_title>A Perspective, Multicentre, Randomizedï¼ŒBlind Study of Residual Curarization Incidence in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eastern Hepatobiliary Surgery Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhujiang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Teaching Hospital of Xinjiang Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei Medical University Fourth Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the incidence of residual curarization in PACU and
      relevant risk factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the last twenty years, residual curarization in PACU (Post Anesthesia Care Unit) has
      become a common problem in clinical practice and poses high risk to patients. The residual
      curarization incidence of Neuromuscular blocking agents (NMBA) varies very much between
      different studies. These differences indicates the necessity of further study. In China,
      there is no common view of the harmfulness of residual curarization and its complications.
      The consensus on the necessity of neuromuscular transmission monitoring and neuromuscular
      blockade antagonist has not been reached yet. There is also no similar large-scale survey in
      China. In this case, the investigators conduct this large scale multicentre study, which is
      designed to learn the incidence of residual curarization and its complications. Further
      analysis of risk factors will also been made. All these efforts are hoped to fill the data
      gap and provide reliable evidences for rational use of NMBA.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of TOFr&lt;0.9</measure>
    <time_frame>From tracheal extubation to 1 minute after extubation</time_frame>
    <description>Once tracheal extubation is performed after the surgery is over, monitor the neuromuscular transmission function (TOF ratio) immediately.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of TOFr&lt;0.9</measure>
    <time_frame>One minute after arriving at PACU</time_frame>
    <description>When patients arrive at PACU(an expected average of 15 minutes after surgery is over), monitor the neuromuscular transmission function (TOF ratio) immediately</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of TOFr&lt;0.7</measure>
    <time_frame>From tracheal extubation to 1 minute after extubation</time_frame>
    <description>Once tracheal extubation is performed after the surgery is over, monitor the neuromuscular transmission function (TOF ratio) immediately.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of TOFr&lt;0.7</measure>
    <time_frame>One minute after arriving at PACU</time_frame>
    <description>When patients arrive at PACU(an expected average of 15 minutes after surgery is over), monitor the neuromuscular transmission function (TOF ratio) immediately</description>
  </secondary_outcome>
  <other_outcome>
    <measure>any sign of residual curarization (listed in description below)</measure>
    <time_frame>First 24h after surgery</time_frame>
    <description>Sign of residual curarization :
dyspnea
weak hand-grip force
Head lift or leg lift time shorter than 5s
aspiration
respiratory rate &gt;20/min
hypoxemia (SpO2&lt;90% when O2&gt;3L/min)</description>
  </other_outcome>
  <other_outcome>
    <measure>pulmonary complications (See description)</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of one week</time_frame>
    <description>pulmonary complications
pneumonia
pulmonary atelectasis
mechanical ventilation required</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">6090</enrollment>
  <condition>Perioperative/Postoperative Complications</condition>
  <condition>PORC (Postoperative Residual Curarization)</condition>
  <arm_group>
    <arm_group_label>Vecuronium Bromide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will be performed general anesthesia and tracheal intubation. Vecuronium will be used during surgery and tracheal extubation is scheduled when surgery is over.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cisatracurium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will be performed general anesthesia and tracheal intubation. Cisatracurium will be used during surgery and tracheal extubation is scheduled when surgery is over.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rocuronium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who will be performed general anesthesia and tracheal intubation. Rocuronium will be used during surgery and tracheal extubation is scheduled when surgery is over.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vecuronium Bromide</intervention_name>
    <description>Administrative protocol of Vecuronium Bromide is determined by each caregiver's clinical experience.</description>
    <arm_group_label>Vecuronium Bromide</arm_group_label>
    <other_name>Norcuron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Administrative protocol of rocuronium is determined by each caregiver's clinical experience.</description>
    <arm_group_label>rocuronium</arm_group_label>
    <other_name>Esmeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisatracurium</intervention_name>
    <description>Administrative protocol of cisatracurium is determined by each caregiver's clinical experience</description>
    <arm_group_label>cisatracurium</arm_group_label>
    <other_name>Nimbex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 or older

          -  Nondepolarized NMBA will be given during surgery and tracheal extubation will be
             performed after surgery

          -  Willing to comply with all study procedures and provide signed and dated informed
             consent

        Exclusion Criteria:

          -  Allergic reaction to gel electrode

          -  Neuromuscular disorders and hepatic or renal dysfunction

          -  Scheduled to receive mechanical ventilation therapy

          -  Involved in other clinical trials

          -  Body position and surgical procedure affecting TOF-Watch SX normal function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinmin Wu, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xinmin Wu, Doctor</last_name>
    <phone>+86 13910616740</phone>
    <email>xmwu2784@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weidong Mi, Doctor</last_name>
      <phone>+86 13381082966</phone>
      <email>wwdd1962@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Zhao, Doctor</last_name>
      <phone>+86 13901048114</phone>
      <email>Zhaojing1009@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuan Zeng, Doctor</last_name>
      <phone>+86 13520703600</phone>
      <email>yuan_zeng@sina.com</email>
    </contact>
    <investigator>
      <last_name>Yuan Zeng, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital, Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenqi Huang, Doctor</last_name>
      <phone>+86 13802963182</phone>
      <email>huangwenqi86@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qinglong Dong, Doctor</last_name>
      <phone>13602837397</phone>
      <email>qldong@163.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhujiang Hospital Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shiyuan Xu, Doctor</last_name>
      <phone>+86 13609727860</phone>
      <email>xushiyuan355@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hebei Medical University Fourth Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zixian Song, Doctor</last_name>
      <phone>+86 13400312688</phone>
      <email>zixiansong@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Zhang, Doctor</last_name>
      <phone>+86 13673996966</phone>
      <email>Zhangw571012@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital, Tongji Medical College of HUST</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ailin Luo, Doctor</last_name>
      <phone>+86 13507122565</phone>
      <email>ailinluo@yahoo.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingping Wu, Doctor</last_name>
      <phone>+86 13971605283</phone>
      <email>Wqp1968@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Junmei Xu, Doctor</last_name>
      <phone>+86 13975148864</phone>
      <email>13975148864@139.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qulian Guo, Doctor</last_name>
      <phone>+86 13707315866</phone>
      <email>qulianguo@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>China Medical University Hospital</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Ma, Doctor</last_name>
      <phone>+86 13840366406</phone>
      <email>mahong5466@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Eastern Hepatobiliary Surgery Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weifeng Yu, Doctor</last_name>
      <phone>+86 13901961704</phone>
      <email>Ywf808@yeah.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>RenJi Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiangrui Wang, Doctor</last_name>
      <phone>13701901953</phone>
      <email>xiangrui68@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingsheng Xue, Doctor</last_name>
      <phone>+86 13611909814</phone>
      <email>xueqingsheng@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai First People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingtian Wang, Doctor</last_name>
      <phone>+86 13386259639</phone>
      <email>wang_didi26@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Zhongshan Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhanggang Xue, Doctor</last_name>
      <phone>13601914601</phone>
      <email>xuezgang@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Liu, Doctor</last_name>
      <phone>+86 13808186401</phone>
      <email>benbinliu@yahoo.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guolin Wang, Doctor</last_name>
      <phone>+86 15822855556</phone>
      <email>wang_guolin@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Teaching Hospital of Xinjiang Medical University</name>
      <address>
        <city>Urumchi</city>
        <state>Xinjiang</state>
        <zip>830000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital Of College of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shenmei Zhu, Doctor</last_name>
      <phone>13857169801</phone>
      <email>smzhu20088@yahoo.com.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, Vandenbroucke G, Deloof T. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006 Feb;102(2):426-9.</citation>
    <PMID>16428537</PMID>
  </reference>
  <reference>
    <citation>Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2010 Jul;111(1):110-9. doi: 10.1213/ANE.0b013e3181c07428. Epub 2009 Nov 12.</citation>
    <PMID>19910616</PMID>
  </reference>
  <reference>
    <citation>Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007 Mar;98(3):302-16. Review.</citation>
    <PMID>17307778</PMID>
  </reference>
  <reference>
    <citation>Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia. 2001 Apr;56(4):312-8.</citation>
    <PMID>11284816</PMID>
  </reference>
  <reference>
    <citation>Baillard C, Clec'h C, Catineau J, Salhi F, Gehan G, Cupa M, Samama CM. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth. 2005 Nov;95(5):622-6. Epub 2005 Sep 23.</citation>
    <PMID>16183681</PMID>
  </reference>
  <reference>
    <citation>Cammu G, de Baerdemaeker L, den Blauwen N, de Mey JC, Struys M, Mortier E. Postoperative residual curarization with cisatracurium and rocuronium infusions. Eur J Anaesthesiol. 2002 Feb;19(2):129-34.</citation>
    <PMID>11999596</PMID>
  </reference>
  <reference>
    <citation>Baillard C, Gehan G, Reboul-Marty J, Larmignat P, Samama CM, Cupa M. Residual curarization in the recovery room after vecuronium. Br J Anaesth. 2000 Mar;84(3):394-5.</citation>
    <PMID>10793602</PMID>
  </reference>
  <reference>
    <citation>Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS. Residual paralysis at the time of tracheal extubation. Anesth Analg. 2005 Jun;100(6):1840-5.</citation>
    <PMID>15920224</PMID>
  </reference>
  <reference>
    <citation>Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003 May;98(5):1042-8.</citation>
    <PMID>12717123</PMID>
  </reference>
  <reference>
    <citation>Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth. 2009 Jul;103(1):115-29. doi: 10.1093/bja/aep093. Epub 2009 May 24. Review. Erratum in: Br J Anaesth. 2009 Oct;103(4):622. Dosage error in article text.</citation>
    <PMID>19468024</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2012</study_first_submitted>
  <study_first_submitted_qc>September 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2012</study_first_posted>
  <last_update_submitted>May 22, 2013</last_update_submitted>
  <last_update_submitted_qc>May 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Xinmin Wu</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>TOFr (train of four ratio)</keyword>
  <keyword>airway extubation</keyword>
  <keyword>PACU (postanesthesia care unit)</keyword>
  <keyword>PORC (postoperative residual curarization)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Delayed Emergence from Anesthesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Atracurium</mesh_term>
    <mesh_term>Vecuronium Bromide</mesh_term>
    <mesh_term>Cisatracurium</mesh_term>
    <mesh_term>Bromides</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

